Highlights NeuroPace, Inc.

Equities

NPCE

US6412881053

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
7.95 ^USD	-0.38%		-6.58%	-22.89%

May. 13	Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating	MT
May. 08	NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Earnings Flash (NPCE) NEUROPACE Posts Q1 Revenue $18.1M, vs. Street Est of $17.3M	May. 08	MT
NeuroPace, Inc. Reaffirms Earnings Guidance for the Year 2024	May. 08	CI
North American Morning Briefing : Inflation -2-	Mar. 15	DJ
NeuroPace Shares Decline Following Q4 Financial Results	Mar. 06	MT
NeuroPace, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
NeuroPace, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 05	CI
Earnings Flash (NPCE) NEUROPACE Reports Q4 Revenue $18M, vs. Street Est of $17.7M	Mar. 05	MT
NeuroPace, Inc. Provides Earnings Guidance for the Year 2024	Mar. 05	CI
NeuroPace Preliminary Q4 Revenue Beats Street View; Shares Rise	Jan. 08	MT
NeuroPace, Inc. Provides Preliminary Revenue Guidance for the Fourth Quarter Ended December 31, 2023	Jan. 08	CI
NeuroPace, Inc. Revises Revenue Guidance for the Full Year 2023	Jan. 08	CI
NeuroPace, Inc. Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study	Dec. 21	CI
NeuroPace, Inc. to Leverage the Power of its RNS System?s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration	Dec. 04	CI
NeuroPace, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Earnings Flash (NPCE) NEUROPACE Reports Q3 Revenue $16.4M, vs. Street Est of $14.2M	Nov. 06	MT
NeuroPace, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Earnings Flash (NPCE) NEUROPACE Reports Q2 Revenue $16.5M, vs. Street Est of $12.6M	23-08-08	MT
NeuroPace, Inc. Revises Earnings Guidance for the Full Year 2023	23-08-08	CI
Exclusive-Musk's Neuralink valued at about $5 billion despite long road to market	23-06-05	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights NeuroPace, Inc.

Equities

NPCE

US6412881053

Highlights

Filters